Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Petrini

Showing results (181-190 of 254) with videos related to

Pageof 26
Sort By:
Anticancer Research|December 1, 2010
ITF2357 interferes with apoptosis and inflammatory pathways in the HL-60 model: a gene expression studySara Galimberti, Martina Canestraro, Hakan Savli, et al.
Leukemia & Lymphoma|August 19, 2007
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimenSara Galimberti, Balint Nagy, Edoardo Benedetti, et al.
Leukemia Research|March 6, 2012
Could age modify the effect of genetic variants in IL6 and TNF-α genes in multiple myeloma?Alessandro Martino, Gabriele Buda, Valentina Maggini, et al.
The Oncologist|November 3, 2010
Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathyMarco Tuccori, Daniele Focosi, Corrado Blandizzi, et al.
American Journal of Clinical Pathology|July 17, 2009
Aberrant expression of CD8 in B-cell non-Hodgkin lymphoma: a multicenter study of 951 bone marrow samples with lymphomatous infiltrationGiovanni Carulli, Alessandra Stacchini, Alessandra Marini, et al.
British Journal of Haematology|May 10, 2007
MDR1 polymorphism influences the outcome of multiple myeloma patientsGabriele Buda, Valentina Maggini, Sara Galimberti, et al.
Acta Haematologica|September 5, 2009
MDR1 C3435T polymorphism indicates a different outcome in advanced multiple myelomaGabriele Buda, Alessandro Martino, Valentina Maggini, et al.
Clinical and Experimental Rheumatology|January 11, 2021
Myeloid neoplasms and autoimmune diseases: markers of associationSara Galimberti, Chiara Baldini, Claudia Baratè, et al.
Leukemia Research|May 22, 2007
Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphismsValentina Maggini, Gabriele Buda, Sara Galimberti, et al.
Tissue Engineering. Part C, Methods|March 30, 2013
Growing bone tissue-engineered niches with graded osteogenicity: an in vitro method for biomimetic construct assemblySerena Danti, Lorenzo Pio Serino, Delfo D'Alessandro, et al.
Pageof 26

Showing results (181-190 of 254) with videos related to

Sort By:
Pageof 26
Anticancer Research|December 1, 2010
ITF2357 interferes with apoptosis and inflammatory pathways in the HL-60 model: a gene expression studySara Galimberti, Martina Canestraro, Hakan Savli, et al.
Leukemia & Lymphoma|August 19, 2007
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimenSara Galimberti, Balint Nagy, Edoardo Benedetti, et al.
Leukemia Research|March 6, 2012
Could age modify the effect of genetic variants in IL6 and TNF-α genes in multiple myeloma?Alessandro Martino, Gabriele Buda, Valentina Maggini, et al.
The Oncologist|November 3, 2010
Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathyMarco Tuccori, Daniele Focosi, Corrado Blandizzi, et al.
American Journal of Clinical Pathology|July 17, 2009
Aberrant expression of CD8 in B-cell non-Hodgkin lymphoma: a multicenter study of 951 bone marrow samples with lymphomatous infiltrationGiovanni Carulli, Alessandra Stacchini, Alessandra Marini, et al.
British Journal of Haematology|May 10, 2007
MDR1 polymorphism influences the outcome of multiple myeloma patientsGabriele Buda, Valentina Maggini, Sara Galimberti, et al.
Acta Haematologica|September 5, 2009
MDR1 C3435T polymorphism indicates a different outcome in advanced multiple myelomaGabriele Buda, Alessandro Martino, Valentina Maggini, et al.
Clinical and Experimental Rheumatology|January 11, 2021
Myeloid neoplasms and autoimmune diseases: markers of associationSara Galimberti, Chiara Baldini, Claudia Baratè, et al.
Leukemia Research|May 22, 2007
Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphismsValentina Maggini, Gabriele Buda, Sara Galimberti, et al.
Tissue Engineering. Part C, Methods|March 30, 2013
Growing bone tissue-engineered niches with graded osteogenicity: an in vitro method for biomimetic construct assemblySerena Danti, Lorenzo Pio Serino, Delfo D'Alessandro, et al.
Pageof 26